Profil
Steve Colletti is currently the Chief Scientific Officer at Korro Bio, Inc. He previously worked as the SVP-Drug Discovery Research & Development at Zymergen, Inc. from 2021 to 2023.
Before that, he was the Chief Scientific Officer at Lodo Therapeutics Corp.
from 2018 to 2021.
Dr. Colletti holds a doctorate degree from Boston University and an undergraduate degree from Loyola University of Chicago.
Aktive Positionen von Steve Colletti
| Unternehmen | Position | Beginn |
|---|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
Ehemalige bekannte Positionen von Steve Colletti
| Unternehmen | Position | Ende |
|---|---|---|
| ZYMERGEN INC. | Corporate Officer/Principal | 01.01.2023 |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2021 |
Ausbildung von Steve Colletti
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymergen, Inc.
Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
















